Enfortumab Vedotin Plus Pembrolizumab vs. Chemotherapy for Untreated la/mUC: EV-302 Study Update ASCO GU 3 Mins Read Dr. Thomas Powles, MBBS, MRCP, MD, from Barts Cancer Institute at Queen Mary University of Londonon February 17, 2025At the…
